Koyfin Home > Directory > Health Care > Acorda Therapeutics > Cash Flow from Operations

Acorda Therapeutics Cash Flow from Operations Chart (ACOR)

Acorda Therapeutics annual/quarterly Cash Flow from Operations from 2010 to 2020. Cash flow from operating activities (CFO) is an accounting item that indicates the amount of money a company brings in from ongoing, regular business activities, such as manufacturing and selling goods or providing a service. Cash flow from operating activities does not include long-term capital or investment costs.
  • Acorda Therapeutics Cash Flow from Operations for the quarter ending June 06, 2020 was $-21m a -17.24% increase of 4m year over year
  • Acorda Therapeutics Cash Flow from Operations for the last 12 months ending June 06, 2020 was $-95m a -35.40% increase of 34m year over year
  • Acorda Therapeutics Annual Cash Flow from Operations for 2019 was $-128m a 217.65% decrease of -279m from 2018
  • Acorda Therapeutics Annual Cash Flow from Operations for 2018 was $151m a 35.58% increase of 54m from 2017
  • Acorda Therapeutics Annual Cash Flow from Operations for 2017 was $97m a 69.48% increase of 67m from 2016
Other Cash Flow Metrics:
  • Acorda Therapeutics Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $60m a 1.90% increase of 1m year over year
  • Acorda Therapeutics Total Revenue for the quarter ending December 12, 2018 was $69m a -53.52% decrease of -37m year over year
View Chart On Koyfin

Quarterly ACOR Cash Flow from Operations Data

06/2020$-21m
03/2020$-39m
12/2019$-11m
09/2019$-24m
06/2019$-15m
03/2019$-77m
12/2018$-12m
09/2018$78m
06/2018$56m
03/2018$29m

Annual ACOR Cash Flow from Operations Data

2019$-128m
2018$151m
2017$97m
2016$30m
2015$38m
2014$75m
2013$39m
2012$52m
2011$66m
2010$-19m